tradingkey.logo

Niagen Bioscience Inc

NAGE
查看詳細走勢圖
5.200USD
+0.070+1.36%
收盤 02/06, 16:00美東報價延遲15分鐘
414.12M總市值
19.83本益比TTM

Niagen Bioscience Inc

5.200
+0.070+1.36%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.36%

5天

-13.19%

1月

-20.85%

6月

-45.89%

今年開始到現在

-18.24%

1年

-5.80%

查看詳細走勢圖

TradingKey Niagen Bioscience Inc股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Niagen Bioscience Inc當前公司基本面數據相對非常健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在生物技術與醫療研究行業排名59/392位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為15.80。中期看,股價處於下降通道。近一個月,市場表現非常差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Niagen Bioscience Inc評分

相關信息

行業排名
59 / 392
全市場排名
178 / 4521
所屬行業
生物技術與醫療研究

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Niagen Bioscience Inc亮點

亮點風險
Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
業績高增長
公司營業收入穩步增長,連續3年增長38.23%
業績增長期
公司處於發展階段,最新年度總收入99.60M美元
業績轉盈
公司業績轉盈,最新年度盈利美元
估值合理
公司最新PE估值19.83,處於3年歷史合理位
PRFDX持倉
明星投資者PRFDX持倉,最新持倉5.11K股

分析師目標

基於 5 分析師
買入
評級
15.800
目標均價
+185.46%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Niagen Bioscience Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Niagen Bioscience Inc簡介

Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
公司代碼NAGE
公司Niagen Bioscience Inc
CEOFried (Robert N)
網址https://www.niagenbioscience.com/
KeyAI